Home / PBM : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PBM make money? Does PBM have pricing power? What's the Earnings Whisper? Will PBM profit more as the business scales? What is PBM's management track record? Is PBM's current price justified?

Psyence Biomedical Ltd.

$5.4 +$0.40 (+8.00%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$4.97

Day Range

$4.93$5.63

Year Range

$1.92$216.41

Market Cap

102.7K

AVG Volume

88.95K

Trailing/Forward PE

0/-

PEG ratio

Dividend Yield

Next Earnings Date

Primary Exchange

NASDAQ

Net Income (CAD)

PBM Net Income (CAD) by year
Period	Net Income (CAD)
2022	5.04M
2021	11.18M

Operating Income (CAD)

PBM Operating Income (CAD) by year
Period	Operating Income (CAD)
2022	-2.09M
2021	-334.29K

EBITDA (CAD)

PBM EBITDA (CAD) by year
Period	EBITDA (CAD)
2022	6.67M
2021	14.2M

Cash Flows (CAD)

PBM Cash Flows (CAD) by year
Period	Cash Flows (CAD)
2022	-853.45K
2021	-1.04M

EPS (CAD)

PBM EPS (CAD) by year
Period	EPS (CAD)
2022	0.17
2021	-0.27

Expenses (CAD)

PBM Expenses (CAD) by year
Period	Expenses (CAD)
2022	3.05M
2021	660.9K

Cash & Debt (CAD)

PBM Cash & Debt (CAD) by year
Period	Cash & Debt (CAD)
2022	15.96K
2021	431.9K

Debt ratios

PBM Debt ratios by year
Period	Debt ratios
2022	0
2021	3.03

Return on Capital

PBM Return on Capital by year
Period	Return on Capital
2022	330.5%
2021	4.67%

Shares Outstanding

PBM Shares Outstanding by year
Period	Shares Outstanding
2022	11.43M
2021	28.54M

Book Value Per Share (CAD)

PBM Book Value Per Share (CAD) by year
Period	Book Value Per Share (CAD)
2022	0.13
2021	8.4

Total Assets (CAD)

PBM Total Assets (CAD) by year
Period	Total Assets (CAD)
2022	16.4M
2021	255.98M

Employee Count

PBM Employee Count by year
Period	Employee Count
2026	12
2025	12
2024	10

PE Ratio

PBM PE Ratio by year
Period	PE Ratio
Feb 24	13860.23
Feb 24	17004.55
Feb 24	20603.31
Feb 24	36798.41
Jan 24	59553.32

Free Cash Flow Yield

PBM Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Jan 25	-0.07%
Jan 25	-0.08%
Jan 25	-0.06%
Dec 24	-0.06%
Dec 24	-0.04%
Dec 24	-0.07%
Dec 24	-0.06%
Nov 24	-0.04%
Nov 24	-0.04%
Nov 24	-0.04%
Nov 24	-0.02%
Nov 24	-0.03%
Oct 24	-0.02%
Oct 24	-0.02%
Oct 24	-0.02%
Oct 24	-0.02%
Sep 24	-0.02%
Sep 24	-0.02%
Sep 24	-0.01%
Sep 24	-0.01%
Aug 24	-0%
Aug 24	-0%
Aug 24	-0%
Aug 24	-0%
Aug 24	-0%
Jul 24	-0%
Jul 24	-0%
Jul 24	-0.01%
Jul 24	-0.01%
Jun 24	-0.01%
Jun 24	-0%
Jun 24	-0%
Jun 24	-0%
May 24	-0%
May 24	-0%
May 24	-0%
May 24	-0%
May 24	-0%
Apr 24	-0%
Apr 24	-0%
Apr 24	-0%
Apr 24	-0%
Mar 24	-0%
Mar 24	-0%
Mar 24	-0%
Mar 24	-0%
Mar 24	-0%
Feb 24	-0.01%
Feb 24	-0.01%
Feb 24	-0%
Feb 24	-0%
Jan 24	-0%

EV/EBITDA

PBM EV/EBITDA by year
Period	EV/EBITDA
Feb 24	8779.59
Feb 24	10771.15
Feb 24	13050.55
Feb 24	23308.26
Jan 24	37720.84

Price to Book

PBM Price to Book by year
Period	Price to Book
Sep 26	0.67
Sep 26	0.57
Aug 26	0.53
Aug 26	0.54
Aug 26	0.43
Aug 26	0.43
Jul 26	0.4
Jul 26	0.37
Jul 26	0.38
Jul 26	0.37
Jul 26	0.38
Jun 26	0.37
Jun 26	0.39
Jun 26	0.42
Jun 26	0.44
May 26	0.52
May 26	0.51
May 26	0.61
May 26	0.7
May 26	0.78
Apr 26	0.99
Apr 26	0.95
Apr 26	0.33
Apr 26	0.31
Mar 26	0.32
Mar 26	0.3
Mar 26	0.31
Mar 26	0.31
Feb 26	0.32
Feb 26	0.31
Feb 26	0.39
Feb 26	0.39
Jan 26	0.5
Jan 26	0.57
Jan 26	0.52
Jan 26	0.63
Jan 26	0.62
Dec 25	0.73
Dec 25	0.75
Dec 25	1.18
Dec 25	1.32
Nov 25	1.15
Nov 25	1.12

No video analysis for this stock yet. Request one from our team.

News: PBM

benzinga.com · 4 Sep 2026

Modular Medical Secures National PBM Contract For Pivot Insulin Pump

Commercial-stage medical device manufacturer Modular Medical Inc. (NASDAQ:MODD) recently signed a significant contract with a national U.S. pharmacy benefit manager (PBM).

globenewswire.com · 18 Aug 2026

Psyence BioMed Welcomes U.S. Administration's Latest Action to Accelerate Ibogaine Development

Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built

businesswire.com · 16 Jun 2026

Tredium Solutions Selected to Support Scripius' Pharmacy Benefits Platform

MINNEAPOLIS--(BUSINESS WIRE)--Tredium Solutions, a provider of pharmacy benefit management (PBM) technologies, has been selected to support the administration of Scripius' commercial, Medicare, and Medicaid pharmacy benefit programs. Through this collaboration, Tredium will provide its claims platform to support accurate and reliable processing for Scripius and the customers it serves. Scripius empowers health plans, health systems, and self-funded employers to better manage rising pharmacy cos.